MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ...

MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ...

Maher Masoud discussed inventory write-down due to product redesign and new engineering head hired for efficient development. Vertex focuses on high-impact workflows and revenue to avoid future losses. Revenue recognition for Cash Chevy includes patient dosing and partnership interactions. More SPL customers target autoimmune diseases, expanding beyond oncology.

Read More

Did you find this insightful?